Advances in living cell-based anticancer therapeutics

2020 ◽  
Vol 8 (9) ◽  
pp. 2344-2365 ◽  
Author(s):  
He Dong ◽  
Xiao Xu ◽  
Leikun Wang ◽  
Ran Mo

This review summarizes recent advances in the applications of living cells as drug carriers or active drugs for anticancer drug delivery and cancer therapy.

2020 ◽  
Vol 26 (15) ◽  
pp. 1637-1649 ◽  
Author(s):  
Imran Ali ◽  
Sofi D. Mukhtar ◽  
Heyam S. Ali ◽  
Marcus T. Scotti ◽  
Luciana Scotti

Background: Nanotechnology has contributed a great deal to the field of medical science. Smart drugdelivery vectors, combined with stimuli-based characteristics, are becoming increasingly important. The use of external and internal stimulating factors can have enormous benefits and increase the targeting efficiency of nanotechnology platforms. The pH values of tumor vascular tissues are acidic in nature, allowing the improved targeting of anticancer drug payloads using drug-delivery vectors. Nanopolymers are smart drug-delivery vectors that have recently been developed and recommended for use by scientists because of their potential targeting capabilities, non-toxicity and biocompatibility, and make them ideal nanocarriers for personalized drug delivery. Method: The present review article provides an overview of current advances in the use of nanoparticles (NPs) as anticancer drug-delivery vectors. Results: This article reviews the molecular basis for the use of NPs in medicine, including personalized medicine, personalized therapy, emerging vistas in anticancer therapy, nanopolymer targeting, passive and active targeting transports, pH-responsive drug carriers, biological barriers, computer-aided drug design, future challenges and perspectives, biodegradability and safety. Conclusions: This article will benefit academia, researchers, clinicians, and government authorities by providing a basis for further research advancements.


Nanoscale ◽  
2019 ◽  
Vol 11 (14) ◽  
pp. 6519-6532 ◽  
Author(s):  
Lucie Reinišová ◽  
Soňa Hermanová ◽  
Martin Pumera

A biomedical perspective is used to assess micro/nanomotor-based anticancer drug delivery systems with recommendations for their effective future development.


RSC Advances ◽  
2016 ◽  
Vol 6 (43) ◽  
pp. 36910-36922 ◽  
Author(s):  
Min Li ◽  
Fangrong Zhang ◽  
Kerong Chen ◽  
Cheng Wang ◽  
Yujie Su ◽  
...  

Schematic illustration of the combination of NPs and MSCs drug delivery systems for cancer therapy.


2019 ◽  
Vol 7 (4) ◽  
pp. 576-585 ◽  
Author(s):  
Yandan Yao ◽  
Phei Er Saw ◽  
Yan Nie ◽  
Ping-Pui Wong ◽  
Linjia Jiang ◽  
...  

A new multifunctional pH-responsive NP platform was developed for targeted anticancer drug delivery and effective breast cancer therapy.


RSC Advances ◽  
2019 ◽  
Vol 9 (44) ◽  
pp. 25592-25601 ◽  
Author(s):  
Adhisankar Vadivelmurugan ◽  
Rajeshkumar Anbazhagan ◽  
Vinothini Arunagiri ◽  
Juin-Yih Lai ◽  
Hsieh-Chih Tsai

In this study, bio-responsive polymeric MoS2 nanocomposites were prepared for use as a drug carrier for cancer therapy.


RSC Advances ◽  
2017 ◽  
Vol 7 (18) ◽  
pp. 11021-11029 ◽  
Author(s):  
Chang Liu ◽  
Yayuan Guan ◽  
Yuling Su ◽  
Lili Zhao ◽  
Fancui Meng ◽  
...  

The core cross-linked polyurethane micelles with redox sensitive and pH-responsive surface charge switchable properties were prepared by using diisocyanates as crosslinkers and studied as anticancer drug carriers.


2017 ◽  
Vol 21 (23) ◽  
Author(s):  
Imran Ali ◽  
Sofi Danish Mukhtar ◽  
Mohammad Nadeem Lone ◽  
Heyam Saad Ali ◽  
Hassan Y. Aboul-Enein

2015 ◽  
Vol 6 (14) ◽  
pp. 2580-2615 ◽  
Author(s):  
Homa Gheybi ◽  
Mohsen Adeli

The combination of two generations of polymers as linear–dendritic copolymers leads to hybrid systems with unique properties, which are of great interest for many applications. Herein, recent advances in anticancer drug delivery systems based on linear–dendritic copolymers have been reviewed.


Sign in / Sign up

Export Citation Format

Share Document